Drug interactions
Doxorubicin + Meningococcal group b vaccine
Severity: Moderate
Doxorubicin and Meningococcal group b vaccine: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Myelosuppressive chemotherapy such as doxorubicin can blunt the antibody response to the vaccine. Protection may therefore be lower than in healthy individuals.
What this interaction means in plain words
Doxorubicin and Meningococcal group b vaccine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Chemotherapy-induced immunosuppression impairs vaccine immune response.
What to do
Where possible, vaccinate at least two weeks before starting chemotherapy or after immune recovery; consider revaccination or antibody checks if given during treatment.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Doxorubicin and Meningococcal group b vaccine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Doxorubicin
Frequently asked questions
Can I take Doxorubicin with Meningococcal group b vaccine?
MediHelp rates the interaction as moderate. Doxorubicin and Meningococcal group b vaccine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Myelosuppressive chemotherapy such as doxorubicin can blunt the antibody response to the vaccine. Protection may therefore be lower than in healthy individuals.
How serious is the interaction between Doxorubicin and Meningococcal group b vaccine?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Where possible, vaccinate at least two weeks before starting chemotherapy or after immune recovery; consider revaccination or antibody checks if given during treatment.
What other medicines interact with Doxorubicin?
MediHelp also lists interactions of Doxorubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cobicistat. The full list is on the Doxorubicin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
